FDA 向 GE 医疗上海公司签发 483,三项观察涉及可见颗粒复检、A 级区操作与数据备份
FDA483:备份QA不在现场
FDA 于 2025 年 10 月 30 日向 GE 医疗上海公司签发 Form FDA 483,列出三项检查观察项。
本文中观点不代表任何公司和组织,如有觉得有冒犯的地方,请于后台联系,我会及时删除。所有分享案例都具有孤立性,仅供参考。
皆为FDA官网披露,就算联系我删了,也没啥意义,而且国内的缺陷,我一般不批注……
FEI 编号:3005292384
表头信息 / Header Information
字段(Field) | 内容(Content) |
企业名称(Firm Name) | GE Healthcare Shanghai Co. Ltd. GE 医疗上海有限公司 |
街道地址(Street Address) | No. 1 Niudun Rd. Pilot Free Trade Zone 中国(上海)自由贸易试验区牛顿路 1 号 |
城市、州、邮编、国家(City, State, ZIP Code, Country) | Shanghai, 201203 China 中国上海市,201203 |
受检机构类型(Type Establishment Inspected) | Sterile Drug Manufacturer 无菌制剂生产商 |
检查日期(Date(s) of Inspection) | 10/23/2025–10/30/2025 2025年10月23日—10月30日 |
签发日期(Date Issued) | 10/30/2025 2025年10月30日 |
检查员信息:Dipesh K Shah, CSO
检查结果:vai
DURING AN INSPECTION OF YOUR FIRM WE OBSERVED:
【中文译文】在对你方企业检查期间,我们观察到:
观察项 1 / Observation 1
Approved drug product container closures are not retested or reexamined as appropriate for identity, strength, quality, and purity after exposure to conditions that might have an adverse effect with subsequent approval or rejection by the quality control unit.
【中文译文】经批准的制剂容器密闭系统在暴露于可能产生不利影响的条件后,未按适当要求对其鉴别、含量、质量和纯度进行重新检验或复查,并由质量控制部门作出后续批准或拒绝的决定。
Specifically,
【中文译文】具体而言:
On February 22, 2024 your firm initiated DEV-11527 which found visible foreign black particles on the xxx wall in xxx Injection filled in xxx. During the investigation it was found that two types of black particles are present which are called Type I (embedded in the xxx wall) and Type II (adhered on the inner surface of the xxx). The investigation found that the black particles also extended to the xxx products. Both the xxx effected batches were manufactured on multiple manufacturing lines. The inspection concluded and determined that the root cause of the black particles is rooted from the supplier of the xxx. The investigation found xxx batches of xxx products that contained black particles (Batches: xxx were rejected and xxx batches were shipped to the US. Prior to shipping of the xxx batches, your firm visually re-inspected the xxx batches.
【中文译文】2024年2月22日,你方发起偏差 DEV-11527,在 xxx 灌装的 xxx 注射液 xxx 壁上发现可见外来黑色颗粒。调查发现存在两种黑色颗粒,分别称为 I 类(嵌入 xxx 壁)和 II 类(粘附于 xxx 内表面)。调查还发现黑色颗粒已扩展到 xxx 产品。两批受影响的 xxx 批次在多个生产线上生产。检查得出结论,确定黑色颗粒的根本原因来自 xxx 的供应商。调查发现 xxx 批 xxx 产品含有黑色颗粒(批次:xxx 被拒收,xxx 批已发运至美国)。在发运 xxx 批次之前,你方对 xxx 批次进行了目视复检。
xxx
【中文译文】xxx
(注:本段为原扫描件涂黑区域,内容不可读,以 xxx 代替。)
After the initial re-inspection of the xxx batches was complete, your firm found additional xxx with adhered and embedded particles in xxx batches xxx xxx Your firm only conducted an AQL test (xxx from each of the total batch) and a 100% re-inspection of the remaining xxx was not conducted although black particles are found present in xxx batches.
【中文译文】在完成对 xxx 批次的首次复检后,你方在 xxx 批次 xxx xxx 中又发现了带有粘附和嵌入颗粒的额外 xxx。你方仅进行了 AQL(可接受质量水平)检验(每批总量的 xxx),且未对剩余 xxx 进行 100% 复检——尽管在 xxx 批次中发现存在黑色颗粒。
观察项 2 / Observation 2
Equipment and utensils are not cleaned, maintained, sanitized at appropriate intervals to prevent contamination that would alter the safety, identity, strength, quality or purity of the drug product.
【中文译文】设备和器具未按适当的时间间隔进行清洁、维护和消毒,以防止会改变制剂安全性、鉴别、含量、质量或纯度的污染。
Specifically,
【中文译文】具体而言:
A- On October 27, 2025, I witness the manufacturing of xxx Injection filled in xxx xxx (Batch #xxx) intended for the US market. The product is manufactured in Line xxx with a target of xxx units. During manufacturing, I witnessed the following:
【中文译文】A- 2025年10月27日,我目睹了 xxx 灌装生产的 xxx 注射液(批号 #xxx),该产品拟销往美国市场。产品在 xxx 生产线上生产,目标产量为 xxx 单位。在制造过程中,我目睹了以下情况:
a. On multiple occasions I observed, two employees removing goggles after entering the Grade A filling area. After removing the goggles, the employees would hang the goggles on the xxx hanger where the goggles contacted the wall of the facility. In addition, employees would also place the goggles on xxx benches near manufacturing activities would take place. According to Line xxx Production Manager inside the filling area is Grade A environment and outside the filling area is Grade C environment.
【中文译文】a. 我多次观察到,两名员工在进入 A 级灌装区后摘下护目镜。摘下后,员工将护目镜挂在 xxx 挂架上,护目镜与厂房墙壁接触。此外,员工还将护目镜放在靠近生产活动的 xxx 工作台/长凳上。据 xxx 生产线生产经理称,灌装区内为 A 级环境,灌装区外为 C 级环境。
b. An employee wearing googles improperly while replenishing stoppers by filling the xxx with xxx stoppers. The employee's forehead and eyebrows were exposed. According to section 18 of QID.020.02_f19, effective date September 15, 2025, states "Particular emphasis shall be placed on the following: All hair is covered". Additionally, when the stopper bag was sprayed with xxx the bottom was never sprayed. That bag was then placed next to the xxx area during manufacturing.
【中文译文】b. 一名员工在通过将 xxx 胶塞装入 xxx 以补充胶塞时,护目镜佩戴不当。该员工的额头和眉毛暴露在外。QID.020.02_f19 第 18 条(生效日期:2025年9月15日)规定:"应特别强调以下内容:所有毛发均应覆盖"。此外,当胶塞袋喷洒 xxx 时,袋子底部从未被喷洒。生产期间,该袋子被放置在与 xxx 区域相邻的位置。
B- Your firm does not have equipment numbers for each equipment used in the filling line. For example, equipment such as xxx, forceps, scissors, etc. are not identified and thus cannot be traced. During the inspection, I observed that your firm uses xxx of xxx for manufacturing line xxx xxx of a xxx was observed to be dented during manufacturing. According to Line xxx Injectable Manager, after the visual inspection of xxx was conducted, they would replace the dented xxx By not having identification on each equipment, there is no way of tracking which xxx in which xxx needs to be replaced. In addition, your firm uses Logbook, titled 'Production xxx Hose xxx tube Change', Logbook # ID163.17, form # QID.053.13_f2. Ver. 3 to document the changing of visually inspect components prior sterilization and record sterilization cycle information. That logbook states that xxx are defined by different identification xxx
【中文译文】B- 你方未对灌装线上使用的每台设备赋予设备编号。例如,xxx、镊子、剪刀等设备未进行标识,因而无法追溯。在检查期间,我观察到你方在 xxx 生产线上使用 xxx 的 xxx。在生产过程中观察到一只 xxx 出现凹陷。据 xxx 生产线注射剂经理称,在对 xxx 进行目视检查后,他们会更换凹陷的 xxx。由于每台设备没有标识,无法追踪哪个 xxx 在哪个 xxx 中需要更换。此外,你方使用标题为"生产 xxx 软管 xxx 管路更换"的日志本(日志编号 #ID163.17,表单编号 QID.053.13_f2,版本 3)来记录灭菌前目视检查部件的更换情况,并记录灭菌周期信息。该日志本规定,xxx 通过不同的标识 xxx 进行界定。
观察项 3 / Observation 3
Appropriate controls are not exercised over computers or related systems to assure that changes in master production and control records or other records are instituted only by authorized personnel.
【中文译文】未对计算机或相关系统实施适当的控制,以确保主生产与控制记录或其他记录的变更仅由授权人员进行。
Specifically,
【中文译文】具体而言:
Specifically, your firm uses xxx unprotected storage drives to backup quality manufacturing data from manufacturing equipment.
【中文译文】具体而言,你方使用 xxx 个未受保护的存储驱动器来备份来自生产设备的质量生产数据。
A- Equipment such as:
1- Filling Lines xxx Equipment # 90275, 82712, and 90278
2- Filling Line xxx Environmental Monitoring System (EMS), Equipment # 90287
3- Filling Line xxx Process Control System, Equipment # 56508
【中文译文】A- 相关设备包括:
1- xxx 灌装线,设备编号 90275、82712 和 90278
2- xxx 灌装线环境监测系统(EMS),设备编号 90287
3- xxx 灌装线工艺控制系统,设备编号 56508
According to Engineering Manager, Quality Assurance (QA) do not verify any data that are backed up from manufacturing equipment. Additionally, QA is not present during any backup process.
【中文译文】据工程经理称,质量保证(QA)部门不核实从生产设备备份的任何数据。此外,QA 在任何备份流程中均不在场。
B- Your firm's SOP, QED.010.23, effective date September 15, 2025 is inadequate because it does not explicitly define that QA needs to be present during backup process, documenting what data has been backup.
【中文译文】B- 你方 SOP QED.010.23(生效日期:2025年9月15日)不充分,因为该文件未明确规定 QA 需要在备份流程中在场并记录已备份的数据。
西门:这里两个点,一个是211.68中要求备份数据应防止篡改,有些检查老师会放大到,哪怕是中转文件夹中亦要开启防删除保护。另一个点是,QA IN LOOP,所有GMP相关流程没有qa比较容易落缺陷……何况备份,这里我觉得不是说必须qa在现场,是没人确保其机制,比如备份是否正常执行,是否有挑选数据等等
来源:BasicPharma搬砖工 · mp.weixin.qq.com